These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 14599813

  • 1. Engineered long terminal repeats of retroviral vectors enhance transgene expression in hepatocytes in vitro and in vivo.
    Yamaguchi K, Itoh K, Ohnishi N, Itoh Y, Baum C, Tsuji T, Nagao T, Higashitsuji H, Okanoue T, Fujita J.
    Mol Ther; 2003 Nov; 8(5):796-803. PubMed ID: 14599813
    [Abstract] [Full Text] [Related]

  • 2. High expression of transgenes mediated by hybrid retroviral vectors in hepatocytes: comparison of promoters from murine retroviruses in vitro and in vivo.
    Ohnishi N, Itoh K, Itoh Y, Baum C, Higashitsuji H, Yamaguchi K, Tsuji T, Okanoue T, Fujita J.
    Gene Ther; 2002 Feb; 9(4):303-6. PubMed ID: 11896470
    [Abstract] [Full Text] [Related]

  • 3. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
    Couture LA, Mullen CA, Morgan RA.
    Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
    [Abstract] [Full Text] [Related]

  • 4. Efficient gene transfer by hybrid retroviral vectors to murine spermatogenic cells.
    Danno S, Itoh K, Baum C, Ostertag W, Ohnishi N, Kido T, Tomiwa K, Matsuda T, Fujita J.
    Hum Gene Ther; 1999 Jul 20; 10(11):1819-31. PubMed ID: 10446922
    [Abstract] [Full Text] [Related]

  • 5. A retroviral vector suitable for ultrasound image-guided gene delivery to mouse brain.
    Jang J, Yoon K, Hwang DW, Lee DS, Kim S.
    Gene Ther; 2012 Apr 20; 19(4):396-403. PubMed ID: 21900964
    [Abstract] [Full Text] [Related]

  • 6. The potent enhancer activity of the polycythemic strain of spleen focus-forming virus in hematopoietic cells is governed by a binding site for Sp1 in the upstream control region and by a unique enhancer core motif, creating an exclusive target for PEBP/CBF.
    Baum C, Itoh K, Meyer J, Laker C, Ito Y, Ostertag W.
    J Virol; 1997 Sep 20; 71(9):6323-31. PubMed ID: 9261349
    [Abstract] [Full Text] [Related]

  • 7. Deletion of a negatively acting sequence in a chimeric GATA-1 enhancer-long terminal repeat greatly increases retrovirally mediated erythroid expression.
    Testa A, Lotti F, Cairns L, Grande A, Ottolenghi S, Ferrari G, Ronchi A.
    J Biol Chem; 2004 Mar 12; 279(11):10523-31. PubMed ID: 14701820
    [Abstract] [Full Text] [Related]

  • 8. Factors affecting the performance of different long terminal repeats in the retroviral vector.
    Kim S, Lee K, Kim MD, Kang S, Joo CW, Kim JM, Kim SH, Yu SS, Kim S.
    Biochem Biophys Res Commun; 2006 May 19; 343(4):1017-22. PubMed ID: 16574062
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
    Weber EL, Cannon PM.
    Hum Gene Ther; 2007 Sep 19; 18(9):849-60. PubMed ID: 17767401
    [Abstract] [Full Text] [Related]

  • 11. Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1.
    Mertz JA, Mustafa F, Meyers S, Dudley JP.
    J Virol; 2001 Mar 19; 75(5):2174-84. PubMed ID: 11160721
    [Abstract] [Full Text] [Related]

  • 12. Protection of hematopoietic cells from O(6)-alkylation damage by O(6)-methylguanine DNA methyltransferase gene transfer: studies with different O(6)-alkylating agents and retroviral backbones.
    Jansen M, Bardenheuer W, Sorg UR, Seeber S, Flasshove M, Moritz T.
    Eur J Haematol; 2001 Jul 19; 67(1):2-13. PubMed ID: 11553261
    [Abstract] [Full Text] [Related]

  • 13. Retroviral vectors for high-level transgene expression in T lymphocytes.
    Engels B, Cam H, Schüler T, Indraccolo S, Gladow M, Baum C, Blankenstein T, Uckert W.
    Hum Gene Ther; 2003 Aug 10; 14(12):1155-68. PubMed ID: 12908967
    [Abstract] [Full Text] [Related]

  • 14. Upstream conserved sequences of mouse leukemia viruses are important for high transgene expression in lymphoid and hematopoietic cells.
    Wahlers A, Kustikova O, Zipfel PF, Itoh K, Koester M, Heberlein C, Li Z, Schiedlmeier B, Skerka C, Fehse B, Baum C.
    Mol Ther; 2002 Sep 10; 6(3):313-20. PubMed ID: 12231166
    [Abstract] [Full Text] [Related]

  • 15. Insertion of two independent enhancers in the long terminal repeat of a self-inactivating vector results in high-titer retroviral vectors with tissue-specific expression.
    Fassati A, Bardoni A, Sironi M, Wells DJ, Bresolin N, Scarlato G, Hatanaka M, Yamaoka S, Dickson G.
    Hum Gene Ther; 1998 Nov 20; 9(17):2459-68. PubMed ID: 9853513
    [Abstract] [Full Text] [Related]

  • 16. In vivo analysis of retroviral enhancer mutations in hematopoietic cells: SP1/EGR1 and ETS/GATA motifs contribute to long terminal repeat specificity.
    Wahlers A, Zipfel PF, Schwieger M, Ostertag W, Baum C.
    J Virol; 2002 Jan 20; 76(1):303-12. PubMed ID: 11739695
    [Abstract] [Full Text] [Related]

  • 17. Enhanced transgene expression in primitive hematopoietic progenitor cells and embryonic stem cells efficiently transduced by optimized retroviral hybrid vectors.
    Ketteler R, Glaser S, Sandra O, Martens UM, Klingmüller U.
    Gene Ther; 2002 Apr 20; 9(8):477-87. PubMed ID: 11948372
    [Abstract] [Full Text] [Related]

  • 18. High-resolution analysis of cytosine methylation in the 5ĺong terminal repeat of retroviral vectors.
    Wang L, Robbins PB, Carbonaro DA, Kohn DB.
    Hum Gene Ther; 1998 Nov 01; 9(16):2321-30. PubMed ID: 9829531
    [Abstract] [Full Text] [Related]

  • 19. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
    Baum C, Hegewisch-Becker S, Eckert HG, Stocking C, Ostertag W.
    J Virol; 1995 Dec 01; 69(12):7541-7. PubMed ID: 7494260
    [Abstract] [Full Text] [Related]

  • 20. Efficient gene transfer and expression in primary B lymphocytes.
    Overell RW, Weisser KE, Hess BW, Ziegler SF, Pleiman CM, Maliszewski C, Grabstein KH.
    J Immunol Methods; 1991 Jul 26; 141(1):53-62. PubMed ID: 1865123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.